Home2021-01-14T12:05:23+00:00

News

The Canisius Wilhelmina Ziekenhuis in Nijmegen is now using CAD4COVID-CT in their clinical practice!

Our CAD4COVID software will help to assess affected lung tissue in COVID-19 patients. We have worked closely together with CWZ over the past month to integrate the solution in their daily workflow, and are really happy with the result.

What we do

Clinical Care

Artificial intelligence can play a substantial role in clinical care. To aid medical specialists in their daily tasks, we develop software products focusing on the analysis of thoracic CT scans, chest X-rays, and retinal images. Our automated analysis solutions are used across the globe for clinical decision making, patient monitoring, treatment planning, and screening.

Clinical Trials & Research

Our deep learning based analysis tools are extensively used in pharmacological and biotechnological trials. Sophisticated quantitative measures for lung diseases like COPD, Asthma, Cystic Fibrosis, ILD and COVID-19 provide valuable insights into disease progression and drug response. Thirona is also actively involved in the academic community and provides quantitative image assessment in numerous academic studies.

Solutions

Artificial Intelligence for analysis of chest CT images

Thirona’s lung quantification software offers analysis of chest CT scans that aids in the detection, evaluation, and treatment planning of lung diseases.

Learn more

Artificial intelligence for analysis of chest X-ray images

CAD4TB is a computer-aided detection system that can detect tuberculosis-related abnormalities in posterior-anterior chest X-rays.

Learn more

Artificial Intelligence for analysis of retina images

RetCAD is a computer-aided detection system that detects abnormalities related to Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR).

Learn more

Certified image analysis service

Thirona offers quantitative image analysis through ISO 13485-certified Image Analysis Service to ensure high-quality results.

Learn more

Partners

Go to Top